Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →Goldiam International reported record FY26 results with consolidated revenue crossing ₹1,000 crore for the first time, reaching ₹1,212.3 crore (+27.5% YoY) and PAT of ₹175.9 crore (+45.7% YoY).
✓ Verified against BSE filing
Goldiam International reported record FY26 results with consolidated revenue crossing ₹1,000 crore for the first time, reaching ₹1,212.3 crore (+27.5% YoY) and PAT of ₹175.9 crore (+45.7% YoY). Q4 revenue grew 21% YoY to ₹2,433 million, with EBITDA margin at 23.9%. Growth was driven by strong US demand for lab-grown diamond jewelry, the hybrid casting model (US+India) which provides tariff immunity and margin expansion, and the ramp-up of the Origam retail chain (24 stores, targeting 45-50 by FY27 exit). Management guided for double-digit revenue growth in FY27 and expects margins to improve further. Key risks include competitive intensity in the Indian B2C lab-grown diamond market and potential execution challenges in scaling Origam stores to profitability.
गोल्डियम इंटरनेशनल ने वित्त वर्ष 2026 में शानदार नतीजे दिए। पहली बार कंपनी की कुल कमाई ₹1,000 करोड़ पार कर गई और ₹1,212.3 करोड़ हो गई, जो पिछले साल से 27.5% ज्यादा है। मुनाफा ₹175.9 करोड़ रहा, जो 45.7% बढ़ा। चौथी तिमाही में कमाई 21% बढ़कर ₹2,433 मिलियन हुई, और मुनाफा मार्जिन 23.9% रहा। यह वृद्धि अमेरिका में लैब-ग्रोन डायमंड ज्वेलरी की मजबूत मांग, अमेरिका और भारत में बनाने के मॉडल (जो टैरिफ से बचाता है और मार्जिन बढ़ाता है), और ओरिगम रिटेल चेन (24 स्टोर, लक्ष्य 45-50) के कारण हुई। कंपनी को अगले साल भी दोहरे अंकों में वृद्धि और मार्जिन में सुधार की उम्मीद है। जोखिमों में भारतीय बाजार में प्रतिस्पर्धा और ओरिगम स्टोर को मुनाफे में लाने की चुनौतियां शामिल हैं।
0 delivered, 0 close, 1 missed.
View Promises →Competitive intensity in Indian B2C lab-grown diamond market
View Risks →Full transcript text is available on this route.
Read Transcript →Origam doubled its store count to 24 operational stores across 12 cities since January 2026.
Order book position as on March 31, 2026 was approximately ₹2,000 million.
Lab-grown diamond jewelry contributed 88.3% to overall export sales mix in Q4 FY26.
Online revenue accounted for 27.4% of total revenue in Q4 FY26.
Management expects overall consolidated revenue to grow in double digits in FY27 over the high base of FY26.
Origam aims to have 45-50 company-owned stores by the end of FY27, with 8-10 more stores operational by September 2026.
Origam targets an exit monthly revenue run rate of ₹7 crore for FY27.
Management plans to spend between ₹4 to ₹4.5 crore on marketing in the first half of FY27.
Company plans to open 12-14 more stores by end of FY26, reaching 24-26 operational stores, and 50 more in first half of next fiscal.
Management expressed confidence in doubling B2B business over 3-5 years driven by wallet share gains and new geographies.
Mature stores (3+ years) expected to achieve ₹40 lakh monthly sales and 2x inventory turnover, driving store-level profitability.
Rising competition from new entrants in the lab-grown diamond jewelry space in India could pressure Origam's market share and margins.
With 12 of 24 stores opened in the last 60 days, achieving store-level break-even and overall profitability for Origam remains a key challenge.
Increased concentration of revenue from top three US retailers poses a risk if any retailer reduces orders or shifts suppliers.
Other expenses rose to 14% of revenue in Q4 due to one-offs; if such costs recur, margins could be impacted.
Aggressive Origam store rollout (50 stores in H1 FY27) may strain operational capabilities and working capital.
Titan's entry with 'Beyond' at lower price points could pressure margins and market share, though management sees it as category-expanding.
While dual-casting mitigates tariffs, any change in US trade policy or consumer demand could impact B2B exports.
Management expects overall consolidated revenue to grow in double digits in FY27 over the high base of FY26.
Rising competition from new entrants in the lab-grown diamond jewelry space in India could pressure Origam's market share and margins.
View Risks →